Prof docs monthly update: January 2026
Your monthly digest of professional document developments.
In total, there are 51 ANZCA and 8 FPM professional documents. Of these, 4 ANZCA and 6 FPM documents are currently either in development, under review, out for stakeholder consultation, or being piloted.
Under development/review*
This section has existing versions hyperlinked. PM = Pain Medicine
- (PM) Scope of clinical practice for specialist pain medicine physicians (under development)
- (PM) Statement on provision of pain medicine care to children and adolescents (under development)
- (PM) Statement on multidisciplinary pain services (under development)
- (PM) Statement on spinal cord stimulators (under development)
- PG21 Guideline on safe practices for central venous line insertion, maintenance and removal (under development)
- PS10(PM) Statement on "Medicinal Cannabis" with particular reference to its use in the management of patients with chronic non-cancer pain and PS10(PM) BP (under review)
- PS12(PM) Position statement on the use of ketamine in the management of chronic non-cancer pain and PS12(PM) BP (under review)
- PG31 Guideline on checking anaesthesia delivery systems 2014 and PG31BP (under review)
- PS64 Position statement on environmental sustainability in anaesthesia and pain medicine practice 2019 and PS64BP (under review)
*Please refer to CP24 Professional document process for further details on the internal review (IR) process.
Post pilot review
Documents under post pilot review have completed the pilot period and are either undergoing feedback review or in the process of approval for the final version.
Final versions
- PS02 Position statement on credentialling and defining the scope of clinical practice in anaesthesia and PS02BP
- PS19 Position statement on monitored care by an anaesthetist and PS19BP
- PG28 Guideline on infection prevention and control in anaesthesia and PG28BP
- PG44 Guideline on advice for retraining or further training in anaesthesia and pain medicine and PG44BP
- PS45 Position statement on patients' rights to pain management and associated responsibilities and PS45BP
- PG46 Guideline on training and practice of perioperative cardiac ultrasound in adults and PG46BP
- PG48 Guideline on the administrative management of substance use disorder in medical practitioners in anaesthesia and pain medicine and PG48BP
- PG69 Guideline on the prevention, investigation and follow up of perioperative hypersensitivity reactions and anaphylaxis and PG69BP
Expressions of interest - PG27 Extracorporeal perfusion
We have received expressions of interest from the Cardiothoracic Vascular and Perfusion SIG and also the Australian Medical Perfusionists association. We are seeking any further expressions of interest from fellows to participate in the review of the following professional document:
- PG27 Extracorporeal perfusion: the review of PG27 Guideline for major extracorporeal perfusion and accompanying background paper PG27BP. We are seeking interest from fellows with particular interest, experience or expertise in this area.
Serving as a document development group (DDG) member provides a valuable opportunity to contribute to safety and quality of care for patients.
If you are interested in being nominated for the DDG, please email us for further information.
